Inserting ex vivo fluorescence confocal microscopy perioperatively in Mohs micrographic surgery expedites bedside assessment of excision margins in recurrent basal cell carcinoma

Dermatology. 2013;227(1):89-92. doi: 10.1159/000353577. Epub 2013 Sep 3.

Abstract

Mohs micrographic surgery can be employed in recurrent basal cell carcinoma, although it is a time-consuming technique. Recently, ex vivo fluorescence confocal microscopy (FCM) has been employed to obtain a fast assessment of tumor margins at the bedside. In our case we successfully employed ex vivo FCM to assess the tumor margins and we treated the persistent tumor with intensity-modulated radiation therapy. Our case demonstrates that a multidisciplinary approach is very efficient in managing complex and recurrent tumors and highlights the benefits of FCM as a new technique that can be used in the surgical theater to speed up the entire procedure.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Carcinoma, Basal Cell / pathology*
  • Carcinoma, Basal Cell / radiotherapy
  • Carcinoma, Basal Cell / surgery*
  • Fluorescence
  • Humans
  • Male
  • Microscopy, Confocal
  • Mohs Surgery / methods*
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Recurrence, Local / radiotherapy
  • Neoplasm Recurrence, Local / surgery*
  • Neoplasm, Residual
  • Point-of-Care Systems
  • Radiotherapy, Intensity-Modulated
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / radiotherapy
  • Skin Neoplasms / surgery*